iRadimed
IRMD
46 hedge funds and large institutions have $16M invested in iRadimed in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 13 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
4.53% less ownership
Funds ownership: 21.28% → 16.75% (-4.5%)
21% less funds holding
Funds holding: 58 → 46 (-12)
37% less capital invested
Capital invested by funds: $25.3M → $16M (-$9.28M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.98M |
| 2 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$657K |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
+$378K |
| 4 |
Goldman Sachs
New York
|
+$302K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$280K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$5.6M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$827K |
| 3 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$764K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$502K |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$437K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Millennium Management
New York
| – | -$273K | -24,557 | Closed |
|
52
Russell Investments Group
London,
United Kingdom
| – | -$96K | -8,565 | Closed |
|
|
SFS
53
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$29K | -3,348 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | -$19K | -1,737 | Closed |
|
55
US Bancorp
Minneapolis,
Minnesota
| – | -$18K | -1,620 | Closed |
|
|
AIM
56
Acrospire Investment Management
Chicago,
Illinois
| – | -$7K | -636 | Closed |
|
|
GT
57
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$4K | -450 | Closed |
|
58
Legal & General Group
London,
United Kingdom
| – | -$2K | -171 | Closed |
|
IRMD Hedge Fund Activity: Q1 2017 in Review
46 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2017, worth a combined $16M — down 37% from $25.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IRMD and 5 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 18 added.
The largest buyer was BlackRock, adding an estimated $1.98M. The largest seller was Conestoga Capital Advisors, exiting entirely with an estimated $5.6M sold.
- 46 institutional investors held iRadimed (IRMD) as of Q1 2017, down from 58 in Q4 2016.
- Funds reported $16M of iRadimed stock for Q1 2017, down 37% quarter-over-quarter.
- 5 funds opened new iRadimed positions in Q1 2017 and 13 closed out, a net change of -8 holders.
- The largest iRadimed buyer in Q1 2017 was BlackRock, an estimated $1.98M added.
- The largest iRadimed seller in Q1 2017 was Conestoga Capital Advisors, an estimated $5.6M sold.
Based on aggregated 13F filings for Q1 2017.